Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

1987 • 19,723 citations

A New Depression Scale Designed to be Sensitive to Change

1979 • 12,729 citations

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride–methanol

1964 • 5,892 citations

REPRODUCIBILITY AND VALIDITY OF A SEMIQUANTITATIVE FOOD FREQUENCY QUESTIONNAIRE

1985 • 4,150 citations

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

Increase in Circulating Products of Lipid Peroxidation (F₂-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage

1995 • 1,343 citations

Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations

1998 • 937 citations

Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

1989 • 862 citations

Alterations in Brain High-Energy Phosphate and Membrane Phospholipid Metabolism in First-Episode, Drug-Naive Schizophrenics

1991 • 481 citations

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia

1998 • 453 citations

Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity.

1997 • 451 citations

Behavioral Deficits Associated with Dietary Induction of Decreased Brain Docosahexaenoic Acid Concentration

2000 • 422 citations

Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans

1999 • 409 citations

Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.

1985 • 372 citations

Smoking and schizophrenia

1992 • 346 citations

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

2000 • 332 citations

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

2001 • 330 citations

A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia

2001 • 327 citations

Delivery and turnover of plasma-derived essential PUFAs in mammalian brain

2001 • 321 citations

Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids

1997 • 295 citations

Comparison of Measures of Fatty Acid Intake by Subcutaneous Fat Aspirate, Food Frequency Questionnaire, and Diet Records in a Free-living Population of US Men

1992 • 281 citations

Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients

2000 • 274 citations

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

1994 • 250 citations

Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

2001 • 232 citations

Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women

1991 • 222 citations

[32] Chemistry of lipid peroxidation

1984 • 219 citations

Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy

1987 • 216 citations

Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans

1998 • 204 citations

An In Vivo Study of the Prefrontal Cortex of Schizophrenic Patients at Different Stages of Illness via Phosphorus Magnetic Resonance Spectroscopy

1995 • 203 citations

Translating research into practice. Considerations for critical care investigators.

2001 • 195 citations

Increased serum phospholipase A2 activity in schizophrenia: a replication study.

1990 • 191 citations

Phospholipase A2s and lipid peroxidation

2000 • 188 citations

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

2001 • 186 citations

Increased Phospholipid Breakdown in Schizophrenia

1997 • 181 citations

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

1996 • 172 citations

Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders

1998 • 157 citations

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1995 • 151 citations

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1994 • 148 citations

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1993 • 138 citations

Relation of Smoking and Alcohol Consumption to Serum Fatty Acids

1996 • 135 citations

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia

1999 • 119 citations

31P Nuclear Magnetic Resonance Spectroscopy: Neurodevelopment and Schizophrenia

1993 • 114 citations

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia

1989 • 112 citations

Phospholipid Spectrum Disorder in Psychiatry Edited By Malcolm Peet, lain Glen and David F. Horrobin. Carnforth: Marius Press. 1996. 340 pp. £71.60 (hb). ISBN 1-871622-10-7

2000 • 109 citations

Study of chronic schizophrenics using ³¹P magnetic resonance chemical shift imaging

1992 • 107 citations

Phospholipid Spectrum Disorder in Psychiatry

1999 • 100 citations

Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study

1994 • 99 citations

Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a 31P chemical shift spectroscopic-imaging study

2000 • 97 citations

Changes in Levels of Phosphorus Metabolites in Temporal Lobes of Drug-Naive Schizophrenic Patients

1999 • 96 citations

31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia

1994 • 96 citations

New protective roles for selected nutrients

1989 • 85 citations

Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes.

2000 • 83 citations

Essential fatty acids in plasma phospholipids in schizophrenics

1989 • 79 citations

Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia

1995 • 69 citations

Formation and Retention of Cotinine during Placental Transfer of Nicotine in Human Placental Cotyledon

1998 • 64 citations

EICOSAPENTAENOIC ACID TREATMENT IN SCHIZOPHRENIA ASSOCIATED WITH SYMPTOM REMISSION, NORMALISATION OF BLOOD FATTY ACIDS, REDUCED NEURONAL MEMBRANE PHOSPHOLIPID TURNOVER AND STRUCTURAL BRAIN CHANGES

2000 • 64 citations

Increased platelet membrane lysophosphatidylcholine in schizophrenia

1991 • 58 citations

A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients

1986 • 58 citations

The role of phospholipase A activity in rat liver microsomal lipid peroxidation.

1987 • 57 citations

Red blood cell membrane dynamics in schizophrenia

1993 • 57 citations

Phosphorus magnetic resonance spectroscopy in schizophrenia: Correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms

1996 • 55 citations

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1994 • 54 citations

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia

1998 • 54 citations

Association of the Ban 1 dimorphic site at the human cytosolic phospholipase A2 gene with schizophrenia

1998 • 53 citations

Phospholipase A2 and the hypofrontality hypothesis of schizophrenia

1996 • 52 citations

Nutrient intake according to education, smoking, and alcohol in Italian women

1997 • 51 citations

Alcohol Consumption in Rhesus Monkeys Depletes Tissues of Polyunsaturated Fatty Acids and Alters Essential Fatty Acid Metabolism

1999 • 48 citations

Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: A 31Phosphorous magnetic resonance spectroscopic imaging study

1995 • 46 citations

Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies☆

1993 • 46 citations

Genetic polymorphisms, lipoproteins and coronary artery disease risk

2001 • 45 citations

Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy

1991 • 45 citations

Diet and lung cancer 20+ years later: More questions than answers?

1997 • 44 citations

Phospholipase A2 Activity in Serum of Neuroleptic-Naive Psychiatric Inpatients

1993 • 44 citations

Schizophrenia, tardive dyskinesia and essential fatty acids

1996 • 43 citations

Comparison between fat intake assessed by a 3-day food record and phospholipid fatty acid composition of red blood cells: Results from the monitoring of cardiovascular disease-Lille study

1995 • 41 citations

Haloperidol Improves Membrane Phospholipid Abnormalities in Temporal Lobes of Schizophrenic Patients

1999 • 38 citations

Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.

1997 • 35 citations

Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic study

1999 • 28 citations

Nicotine-induced inhibition of neuronal phospholipase A2.

1997 • 28 citations

Influence of Nicotine and Cotinine on Retinal Phospholipase A₂ and its Significance to Macular Function

1998 • 27 citations

31P Nuclear Magnetic Resonance Spectroscopy

1996 • 26 citations

Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients

1991 • 19 citations

Dietary change after smoking cessation: A prospective study

1995 • 18 citations

Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study

2001 • 15 citations

No differences in phospholipase-A2 activity between acute psychiatric patients and controls

1997 • 15 citations

Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31 P-MRS and CT studies

2000 • 13 citations

Brain Lipids and Disorders in Biological Psychiatry

2002 • 13 citations

Deleted Work

1955 • 0 citations